Radiomedix Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Radiomedix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10523
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Radiomedix Inc (Radiomedix) is a biotechnology company that develops and commercializes radiopharmaceuticals for diagnosis and therapy of cancer. The company’s products include radioisotopes, fully automated synthesizers, semi-automated synthesizers, GMP cassettes and consumables, smartmedix system and glucomedix, among others. Radiomedix’s services include radiochemistry and drug design service, CGMP drug manufacturing suite and microPET imaging laboratory. The company has developed its own chelation technology and new imaging conjugates to improve diagnosis and treatment monitoring for a variety of cancers. It also develops radiolabeled agent that targets hedgehog signaling pathway and can be used in diagnosis and staging of lung, ovarian, breast, gastrointestinal, hematological, prostate, skin cancer, and others. The company serves nuclear medicine researchers and clinicians. Radiomedix is headquartered in Houston, Texas, the US.

Radiomedix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Radiomedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Radiomedix Inc, Medical Devices Deals, 2012 to YTD 2018 9
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Radiomedix Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
RadioMedix Enters into Distribution Agreement with ITG Isotope 11
RadioMedix Enters into Co-Development Agreement with Areva Med 12
RadioMedix Enters Into Distribution Agreement With ITG Isotope Technologies 13
Licensing Agreements 14
Endocyte Receives Rights from Radiomedix 14
Radiomedix Inc – Key Competitors 15
Radiomedix Inc – Key Employees 16
Radiomedix Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Radiomedix Inc, Pharmaceuticals & Healthcare, Key Facts 2
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Radiomedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Radiomedix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Radiomedix Inc, Medical Devices Deals, 2012 to YTD 2018 9
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
RadioMedix Enters into Distribution Agreement with ITG Isotope 11
RadioMedix Enters into Co-Development Agreement with Areva Med 12
RadioMedix Enters Into Distribution Agreement With ITG Isotope Technologies 13
Endocyte Receives Rights from Radiomedix 14
Radiomedix Inc, Key Competitors 15
Radiomedix Inc, Key Employees 16

List of Figures
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Radiomedix Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Radiomedix Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Poudre Valley Rural Electric Association, Inc.:発電所・企業SWOT分析
    Poudre Valley Rural Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, i …
  • Sanochemia Pharmazeutika AG (SAC)-製薬・医療分野:企業M&A・提携分析
    Summary Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio i …
  • Taragenyx Ltd:企業の製品パイプライン分析2018
    Summary Taragenyx Ltd (Taragenyx) is a medical technology company that provides regenerative medicine technology, medical and biological engineering solutions. The company offers restorative implant solutions generation, burdensome operations, and medical, orthopaedic, dental implantation solutions, …
  • GenapSys Inc:医療機器:M&Aディール及び事業提携情報
    Summary GenapSys Inc (GenapSys) is engaged in the development of DNA sequencing technologies for applied genomic testing, and medical sequencing. The company offers a Gene Electronic Nano-Integrated Ultra-Sensitive (GENIUS) technology platform that identifies the genome and delivers the insights of …
  • Lagardere SCA:企業のM&A・事業提携・投資動向
    Lagardere SCA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lagardere SCA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • China Petrochemical Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China Petrochemical Corp (Sinopec Corp) is a petroleum and petrochemical company. The company is engaged in the engaged in the exploration and production, pipeline transportation, and sale of petroleum and natural gas. It is also involved in the production, sale, storage and transportation o …
  • Panhandle Oil and Gas Inc (PHX):企業の財務・戦略的SWOT分析
    Panhandle Oil and Gas Inc (PHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Pennon Group Plc:企業の戦略・SWOT・財務分析
    Pennon Group Plc - Strategy, SWOT and Corporate Finance Report Summary Pennon Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SCB Life Assurance Public Company Limited:戦略・SWOT・企業財務分析
    SCB Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary SCB Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Delta International Oil & Gas Inc (DLTZ):石油・ガス:M&Aディール及び事業提携情報
    Summary Delta International Oil & Gas Inc (Delta), formerly Delta Mutual Inc, is an oil and gas company. The company operates in the oil and gas acquisition and exploration activities. It also holds interests in oil and natural gas and development rights in Argentina. Delta’s oil and gas investments …
  • VeriFone Systems Inc:企業のM&A・事業提携・投資動向
    VeriFone Systems Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VeriFone Systems Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Liberty Global plc:企業のM&A・事業提携・投資動向
    Liberty Global plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Liberty Global plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • PGNiG SA (PGN):石油・ガス:M&Aディール及び事業提携情報
    Summary PGNiG SA (PGNiG) is a vertically integrated gas company. The company’s activities include domestic natural gas and crude oil production, development of natural gas and crude oil fields in Poland and abroad, provision of geological, geophysical and exploration services in Poland and abroad, i …
  • Genomic Health Inc (GHDX)-医療機器分野:企業M&A・提携分析
    Summary Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company’s commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer …
  • Bancolombia SA (BCOLOMBIA):企業の財務・戦略的SWOT分析
    Bancolombia SA (BCOLOMBIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Martin Midstream Partners L.P.:企業の戦略・SWOT・財務情報
    Martin Midstream Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Martin Midstream Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Laval University:製薬・医療:M&Aディール及び事業提携情報
    Summary Laval University is an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate, degree programs and distance education programs. It offers courses in the fields of advanced international studies, agriculture and food scien …
  • CITIC Ltd (267)-エネルギー分野:企業M&A・提携分析
    Summary CITIC Limited (CITIC) is a conglomerate that is active in diverse business areas such as financial services, resources and energy, manufacturing, engineering contracting, and real estate and infrastructure. Its financial services include banking, trust, asset management, securities and insur …
  • Tata Chemicals Ltd (TATACHEM):企業の財務・戦略的SWOT分析
    Summary Tata Chemicals Ltd (TCL) operates as a chemical company engaged in offering industry, living, and farm essential chemicals. The company's products include dals, consumer salt, water purifier, soda ash, spices, sodium bicarbonate, allied chemicals, industrial salt, customized fertilizers, cem …
  • SeQuent Scientific Ltd (512529):企業の財務・戦略的SWOT分析
    Summary SeQuent Scientific Ltd (SeQuent) is a pharmaceutical company that develops and manufactures animal health API, life science and industrial products. The company offers products such as aciclovir sodium, albendazole, artemether, artesunate, amyl meta cresol, citicoline sodium and dihydroartem …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆